全球幽門螺旋桿菌非侵入性檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，幽門螺旋桿菌非侵入性檢測市場規模將達到 10.0301 億美元，高於 2025 年的 6.6 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 4.76%。

受胃腸道感染疾病日益普遍以及對便捷診斷方法需求不斷成長的推動，全球幽門螺旋桿菌非侵入性檢測市場正穩步成長。幽門螺旋桿菌是一種會引起胃潰瘍的細菌，也與某些類型的胃癌有關。呼吸檢測、糞便抗原檢測和血液檢測等非侵入性檢測方法被廣泛用於診斷。

推動該市場發展的主要因素是人們對消化器官系統健康的日益關注以及對早期診斷重要性的持續認知。與內視鏡檢查等侵入性檢查相比，非侵入性診斷測試更安全、更舒適、更易於操作，因此更受青睞。此外，診斷技術的進步也提高了測試的準確性和可靠性。

隨著醫療專業人員日益重視早期檢測和預防醫學，非侵入性幽門螺旋桿菌檢測市場預計將會擴大。醫療保健投資的增加和診斷基礎設施的改善將促進先進檢測方法的應用。此外，人們對胃腸道疾病認知的提高也有望推動市場成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球幽門螺旋桿菌非侵入性檢測市場：按類型分類

• 市場分析、洞察與預測
• 血清學檢測
• 糞便抗原檢測
• 尿素呼吸檢測

第5章 全球幽門螺旋桿菌非侵入性檢測市場：依檢測類型分類

• 市場分析、洞察與預測
• 檢查室檢測
• 即時檢測

第6章：全球幽門螺旋桿菌非侵入性檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 診斷檢查室

第7章 全球幽門螺旋桿菌非侵入性檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • DiaSorin SpA
  • Meridian BioscienceInc
  • Exalenz Bioscience Ltd
  • Abbott
  • Thermo Fisher Scientific
  • BiomericaInc
  • Certest Biotec SL
  • Sekisui Diagnostics
  • Coris BioConcept
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • Alere
  • Bio-Rad LaboratoriesInc
  • Cardinal Health
  • Fisher Scientific
  • Quidel Corporation

The Helicobacter Pylori Non-Invasive Testing Market size is expected to reach USD 1003.01 Million in 2034 from USD 660.00 Million (2025) growing at a CAGR of 4.76% during 2026-2034.

The global Helicobacter pylori non-invasive testing market is growing steadily due to the rising prevalence of gastrointestinal infections and increasing demand for convenient diagnostic methods. Helicobacter pylori is a bacterium that can cause stomach ulcers and is associated with certain types of gastric cancer. Non-invasive testing methods such as breath tests, stool antigen tests, and blood tests are widely used for diagnosis.

A major driver of this market is the increasing awareness of gastrointestinal health and the importance of early diagnosis. Non-invasive diagnostic tests are preferred because they are safer, more comfortable for patients, and easier to perform compared to invasive procedures such as endoscopy. Additionally, advancements in diagnostic technologies are improving test accuracy and reliability.

In the future, the Helicobacter pylori non-invasive testing market is expected to expand as healthcare providers emphasize early detection and preventive care. Growing healthcare investments and improved diagnostic infrastructure will support the adoption of advanced testing methods. Increasing awareness about gastrointestinal diseases is also expected to drive market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serology Test
• Stool Antigen Test
• Urea Breath Test

By Test Type

• Laboratory-based Tests
• Point-of-Care Tests

By End-User

• Hospitals
• Clinics
• Diagnostic Laboratories

COMPANIES PROFILED

• DiaSorin SpA, Meridian Bioscience, Inc, Exalenz Bioscience Ltd, Abbott, Thermo Fisher Scientific, Biomerica, Inc, Certest Biotec SL, Sekisui Diagnostics, Coris BioConcept, Shenzhen Zhonghe Headway BioSci Tech Co, Ltd, Alere, BioRad Laboratories, Inc, Cardinal Health, Fisher Scientific, Quidel Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serology Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stool Antigen Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urea Breath Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Laboratory-based Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-of-Care Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DiaSorin S.p.A
  • 9.2.2 Meridian BioscienceInc
  • 9.2.3 Exalenz Bioscience Ltd
  • 9.2.4 Abbott
  • 9.2.5 Thermo Fisher Scientific
  • 9.2.6 BiomericaInc
  • 9.2.7 Certest Biotec S.L
  • 9.2.8 Sekisui Diagnostics
  • 9.2.9 Coris BioConcept
  • 9.2.10 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • 9.2.11 Alere
  • 9.2.12 Bio-Rad LaboratoriesInc
  • 9.2.13 Cardinal Health
  • 9.2.14 Fisher Scientific
  • 9.2.15 Quidel Corporation